IP Library Granted Patent US 8,864,646
Granted Patent B2
US 8,864,646 · App. 11/202,315 · Granted Oct 21, 2014

Surgical articles and methods

Inventors: Johann J. Neisz (Coon Rapids, MN); Robert E. Lund (St. Michael, MN); Kimberly A. Anderson (Eagan, MN); Vicki R. Vandersloot (Minneapolis, MN); Terence M. Moore (Tomkins Cove, NY); Mark S. Bouchier (Lakeville, MN); Randy L. Morningstar (Brooklyn Park, MN); Gary A. Rocheleau (Maple Grove, MN)
Assignee: AMS Research Corporation
A61B17/06004A61F2/0045A61B17/0469A61B17/30A61B17/42A61B2017/06014A61B17/0487A61B2017/00464A61F2250/0007A61B2017/06009A61B17/0482A61F2002/3055A61B17/0401A61B17/06066A61B2017/06085A61B2017/00946A61B2017/00805A61B17/06109A61B2017/0046A61B2017/06042A61B2017/0458A61B17/3211A61B19/026A61B2017/0454A61B19/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,864,646
App. No.
11/202,315
Granted
Oct 21, 2014
Kind
B2
Abstract

Surgical instruments, implantable articles and surgical procedures disclosed for treating medical disorders, particularly incontinence. Improved surgical sling procedures are disclosed. Novel surgical instruments and kits for use in sling procedures are also disclosed. The present invention affords options for surgeons with concomitant advantages to the patient and the healthcare provider.

Claims (26)

1. A sling system for treating urinary incontinence in a patient, comprising:

a sling assembly including;

an elongate mesh implant having a central portion and extension portions, wherein the central portion is positionable under the urethra of a patient and the extension portions are extendable away from the urethra;

a dilator;

a needle device to facilitate deployment of the sling assembly within the patient including;

an elongate needle having a needle length, an interior lumen, and an elongate member having a distal end and movable with the interior lumen, wherein the elongate member is adapted for operable engagement with the mesh implant, and the distal end includes a snap engagement feature to selectively engage the dilator; and

a handle having an actuation mechanism, the actuation mechanism having an actuator and a spring member in operable communication with the elongate member, wherein the spring member biases the elongate member in an extended position a distance out from the elongate needle less than half the needle length, and the actuator is adapted to retract the elongate member within the elongate needle.

2. The sling system of claim 1 , further including visual indicia to facilitate centering of the mesh implant relative to the urethra.

3. The sling system of claim 1 , further including a sheath having first and second portions adapted to overlap proximate the central portion of the mesh implant.

4. The sling system of claim 3 , wherein the sheath is made at least in part of a polymer material.

5. The sling system of claim 1 , wherein a portion of the needle device is curved.

6. The sling system of claim 1 , wherein the mesh implant is made of a porous polymer material.

7. The sling system of claim 1 , wherein an end of the elongate member is adapted for operable engagement with at least the mesh implant.

8. The sling system of claim 1 , further including an adapter portion configured to provide operable engagement between the mesh implant and the needle device.

9. A sling system for treating urinary incontinence in a patient, comprising:

a sling assembly including;

an elongate mesh implant having a central portion and extension portions, wherein the central portion is positionable under the urethra or bladder neck of a patient and the extension portions are extendable away from the urethra or bladder neck;

a dilator;

a needle device to facilitate deployment of the sling assembly within the patient having

an elongate needle having a needle length, an interior lumen, and an elongate member having a distal tip and is adapted to move with the interior lumen, wherein the elongate member is adapted for operable engagement with the mesh implant and the distal tip snappingly engages with the dilator; and

a handle having an actuator and a spring member in operable communication with the elongate member, wherein the spring member biases the elongate member in an extended position a distance out from the elongate needle less than half the needle length, and the actuator is adapted to retract the elongate member within the elongate needle.

10. The sling system of claim 9 , further including a sheath having first and second portions.

11. The sling system of claim 10 , wherein the sheath is made at least in part of a polymer material.

12. The sling system of claim 9 , wherein a portion of the needle device is curved.

13. The sling system of claim 9 , wherein the mesh implant is made of a porous polymer material.

14. The sling system of claim 9 , further including an adapter portion configured to provide operable engagement between the mesh implant and the needle device.

Assignments (18)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 032379/0501 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 21, 2011
From: AMERICAN MEDICAL SYSTEMS, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026628/0260 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2011
From: CIT HEALTHCARE LLC
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 026142/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2007
From: AMERICAN MEDICAL SYSTEMS, INC.
To: AMS RESEARCH CORPORATION
Reel/Frame 019697/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2007
From: NEISZ, JOHANN J.; LUND, ROBERT E.; ANDERSON, KIMBERLY A.; VANDERSLOOT, VICKI R.; MOORE, TERENCE M.; BOUCHIER, MARK S.; MORNINGSTAR, RANDY L.; ROCHELEAU, GARY A.
To: AMERICAN MEDICAL SYSTEMS INC.
Reel/Frame 019585/0836 →
SECURITY AGREEMENT Recorded Aug 18, 2006
From: AMERICAN MEDICAL SYSTEMS, INC.
To: CIT HEALTHCARE LLC
Reel/Frame 018132/0639 →
Continuity (10)
Continuation 10280945 · Oct 25, 2002
Continuation 10005837 · Nov 9, 2001
Continuation In Part 09917562 · Jul 27, 2001
Continuation In Part 09917443 · Jul 27, 2001
Provisional Application 60263472 · Jan 23, 2001
Provisional Application 60269829 · Feb 20, 2001
Provisional Application 60281350 · Apr 4, 2001
Provisional Application 60295068 · Jun 1, 2001
Provisional Application 60306915 · Jul 20, 2001
Related Publication 20060183966A1 · Aug 17, 2006